Skip to main content
OpenTrials

Clinical trial condition

Brain Diseases, Metabolic

Explore clinical trials studying Brain Diseases, Metabolic. Study availability and eligibility vary by location and protocol.

1,103 public trials 225 recruiting studies
Refine in advanced search Browse all conditions

Brain Diseases, Metabolic trial results

Completed

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

NCT02675465

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Neuromuscular Research Centre Phoenix, Arizona, United States
  • University of California Irvine Orange, California, United States
  • University of Florida Gainesville, Florida, United States
  • Emory University Division of Medical Genetics Decatur, Georgia, United States
View all 19 locations
View Trial Details
Completed

A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

NCT06019728

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • UCLA Medical Center Site Number : 1003 Santa Monica, California, United States
  • Emory University School of Medicine Site Number : 1005 Atlanta, Georgia, United States
  • Infusion Associates Site Number : 1001 Grand Rapids, Michigan, United States
  • Metropolitan Hospital Center Site Number : 1004 New York, United States
View Trial Details
Completed

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies

NCT05409846

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Centro Hospitalar Universitário de Coimbra Coimbra, Portugal
  • Hospital da Luz, Lisboa Lisbon, Portugal
  • Centro Hospitalar Universitário Lisboa Norte, EPE., Hospital de Santa Maria Lisbon, Portugal
  • Hospital Pedro Hispano (Unidade Local de Saúde Matosinhos) Matosinhos Municipality, Portugal
View Trial Details
Completed

GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

NCT05109793

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Hospital Pequeno Principe Curitiba, Brazil
  • Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil
View all 13 locations
View Trial Details
Completed

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

NCT04845958

Conditions
Acid Sphingomyelinase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +25 more
Locations
  • Investigational Site Number 2500036 Amiens, France
  • Investigational Site Number 2500014 Angers, France
  • Investigational Site Number 2500034 Argenteuil, France
  • Investigational Site Number 2500039 Bayonne, France
View all 40 locations
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ

NCT04656600

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Investigational Site Number : 107 Beijing, China
  • Investigational Site Number : 101 Beijing, China
  • Investigational Site Number : 104 Chengdu, China
  • Investigational Site Number : 102 Guangzhou, China
View Trial Details
Completed

PheCheck Feasibility Study

NCT05998109

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +9 more
Locations
  • UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

China Post-marketing Surveillance (PMS) Study of Fabrazyme®

NCT05054387

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Investigational Site Number :1560003 Beijing, China
  • Investigational Site Number :1560002 Beijing, China
  • Investigational Site Number :1560001 Shanghai, China
  • Investigational Site Number :1560004 Shanghai, China
View Trial Details
Completed

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

NCT03729362

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
  • UF Helath: University of Florida Clinical Research Center Gainesville, Florida, United States
View all 73 locations
View Trial Details

Related conditions